Scientific Sessions 2024  /  Celebrating a Century of Cardiovascular Science: From Prevention to Treatment, to Cure  /  Discussant: BPROAD
Logo

American Heart Association

  9
  0

Final ID:

Discussant: BPROAD

  • Prabhakaran, Dorairaj  ( Centre for Chronic Disease Control , Delhi , India )
    • Author Disclosures:
    Dorairaj Prabhakaran: DO have relevant financial relationships ; Research Funding (PI or named investigator):SERDIA PHARMACEUTICALS (INDIA) PRIVATE LIMITED:Past (completed) ; Research Funding (PI or named investigator):Servier Affaires Médicales:Active (exists now) ; Research Funding (PI or named investigator):Imperial College London:Active (exists now)
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

Celebrating a Century of Cardiovascular Science: From Prevention to Treatment, to Cure

Saturday, 11/16/2024 , 08:30AM - 09:45AM

Late-Breaking Science

More abstracts on this topic:
Nexiguran ziclumeran (nex-z, also known as NTLA-2001), an investigational in vivo CRISPR-based therapy for patients with transthyretin amyloidosis with cardiomyopathy (ATTR-CM): interim report of the Phase 1 study

Fontana Marianna, Olbertz Joy, Zhu Peijuan, Boiselle Carri, Smith Derek, Leung Adia, Gutstein David, Sonderfan Alison, Walsh Liron, Gillmore Julian, Taubel Jorg, Gane Edward, Pilebro Bjorn, Adams David, Solomon Scott, Claggett Brian, Kachadourian Jessica, Rocha Ricardo

Discussant: SUMMIT

Sweitzer Nancy

More abstracts from these authors:
Fixed-dose combination therapy: Opportunities and challenges for improved CVD prevention

Prabhakaran Dorairaj, Murphy Adrianna, Irazola Vilma

International Collaboration in Multinational Clinical Trials

Faubert Christine, Tancredi David, Prabhakaran Dorairaj

You have to be authorized to contact abstract author. Please, Login
Not Available